Enanta Pharmaceuticals
ENTA
#8687
Rank
C$0.34 B
Marketcap
C$11.90
Share price
-4.37%
Change (1 day)
-33.93%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Total debt

Total debt on the balance sheet as of June 2026 : C$79.7 Million

According to Enanta Pharmaceuticals 's latest financial reports the company's total debt is C$79.7 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Enanta Pharmaceuticals - Total debt on balance sheet (from 2014 to 2026)

Total debt by year

Year Total debt Change
2025-09-30C$80.62 M7.45%
2024-09-30C$75.03 M108.23%
2023-09-30C$36.03 M3.52%
2022-09-30C$34.8 M414.97%
2021-09-30C$6.75 M-37.27%
2020-09-30C$10.77 M3968.86%
2019-09-30C$0.26 M-29.61%
2018-09-30C$0.37 M-19.98%
2017-09-30C$0.47 M-32.74%
2016-09-30C$0.69 M-12.23%
2015-09-30C$0.79 M
2014-09-30N/A

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
C$63.94 B 80,126.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$69.18 B 86,701.06%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
C$101.42 B 127,149.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$2.83 B 3,453.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$77.20 B 96,755.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$64.17 B 80,412.43%๐Ÿ‡บ๐Ÿ‡ธ USA